228 related articles for article (PubMed ID: 11898532)
1. Fatigue in multiple sclerosis.
Krupp LB; Christodoulou C
Curr Neurol Neurosci Rep; 2001 May; 1(3):294-8. PubMed ID: 11898532
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological treatments for fatigue associated with palliative care.
Mücke M; ; Cuhls H; Peuckmann-Post V; Minton O; Stone P; Radbruch L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD006788. PubMed ID: 26026155
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological treatments for fatigue associated with palliative care.
Peuckmann V; Elsner F; Krumm N; Trottenberg P; Radbruch L
Cochrane Database Syst Rev; 2010 Nov; (11):CD006788. PubMed ID: 21069692
[TBL] [Abstract][Full Text] [Related]
4. Fatigue in multiple sclerosis - a brief review.
Induruwa I; Constantinescu CS; Gran B
J Neurol Sci; 2012 Dec; 323(1-2):9-15. PubMed ID: 22935407
[TBL] [Abstract][Full Text] [Related]
5. Treating fatigue in patients with MS: one step forward, one step back.
Schwid SR; Murray TJ
Neurology; 2005 Apr; 64(7):1111-2. PubMed ID: 15824329
[No Abstract] [Full Text] [Related]
6. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
Nourbakhsh B; Revirajan N; Waubant E
Contemp Clin Trials; 2018 Jan; 64():67-76. PubMed ID: 29113955
[TBL] [Abstract][Full Text] [Related]
7. Fatigue associated with multiple sclerosis: diagnosis, impact and management.
Bakshi R
Mult Scler; 2003 Jun; 9(3):219-27. PubMed ID: 12814166
[TBL] [Abstract][Full Text] [Related]
8. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.
Krupp LB; Coyle PK; Doscher C; Miller A; Cross AH; Jandorf L; Halper J; Johnson B; Morgante L; Grimson R
Neurology; 1995 Nov; 45(11):1956-61. PubMed ID: 7501140
[TBL] [Abstract][Full Text] [Related]
9. Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
Brañas P; Jordan R; Fry-Smith A; Burls A; Hyde C
Health Technol Assess; 2000; 4(27):1-61. PubMed ID: 11074395
[TBL] [Abstract][Full Text] [Related]
10. Management of fatigue in patients with multiple sclerosis.
Zifko UA
Drugs; 2004; 64(12):1295-304. PubMed ID: 15200345
[TBL] [Abstract][Full Text] [Related]
11. The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.
Geisler MW; Sliwinski M; Coyle PK; Masur DM; Doscher C; Krupp LB
Arch Neurol; 1996 Feb; 53(2):185-8. PubMed ID: 8639070
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.
Nourbakhsh B; Revirajan N; Morris B; Cordano C; Creasman J; Manguinao M; Krysko K; Rutatangwa A; Auvray C; Aljarallah S; Jin C; Mowry E; McCulloch C; Waubant E
Lancet Neurol; 2021 Jan; 20(1):38-48. PubMed ID: 33242419
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis.
Yang TT; Wang L; Deng XY; Yu G
J Neurol Sci; 2017 Sep; 380():256-261. PubMed ID: 28870581
[TBL] [Abstract][Full Text] [Related]
14. Treating fatigue.
Lapierre Y; Hum S
Int MS J; 2007 Jun; 14(2):64-71. PubMed ID: 17686346
[TBL] [Abstract][Full Text] [Related]
15. [Pathophysiology and treatment of fatigue in multiple sclerosis].
Boërio D; Lefaucheur JP; Hogrel JY; Créange A
Rev Neurol (Paris); 2006 Mar; 162(3):311-20. PubMed ID: 16585886
[TBL] [Abstract][Full Text] [Related]
16. A randomized pragmatic trial of telephone-delivered cognitive behavioral-therapy, modafinil, and combination therapy of both for fatigue in multiple sclerosis: The design of the "COMBO-MS" trial.
Kratz AL; Alschuler KN; Ehde DM; von Geldern G; Little R; Kulkarni S; Pickup K; Braley TJ
Contemp Clin Trials; 2019 Sep; 84():105821. PubMed ID: 31400515
[TBL] [Abstract][Full Text] [Related]
17. Association of a deficit of arousal with fatigue in multiple sclerosis: effect of modafinil.
Niepel G; Bibani RH; Vilisaar J; Langley RW; Bradshaw CM; Szabadi E; Constantinescu CS
Neuropharmacology; 2013 Jan; 64():380-8. PubMed ID: 22766394
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease.
Breitbart W; Rosenfeld B; Kaim M; Funesti-Esch J
Arch Intern Med; 2001 Feb; 161(3):411-20. PubMed ID: 11176767
[TBL] [Abstract][Full Text] [Related]
19. ["Fatigue" in multiple sclerosis].
Hohlfeld R
Nervenarzt; 2000 Aug; 71(8):686. PubMed ID: 10996922
[No Abstract] [Full Text] [Related]
20. Evaluating the effects of amantadin, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis--result of a pilot randomized, blind study.
Ledinek AH; Sajko MC; Rot U
Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S86-9. PubMed ID: 24321164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
